Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.

Narciclasine (1) is a plant growth regulator that has been previously demonstrated to be proapoptotic to cancer cells at high concentrations (> or = 1 microM). Data generated in the present study show that narciclasine displays potent antitumor effects in apoptosis-resistant as well as in apoptosis-sensitive cancer cells by impairing the organization of the actin cytoskeleton in cancer cells at concentrations that are not cytotoxic (IC(50) values of 30-90 nM). The current study further revealed that any chemical modification to the narciclasine backbone generally led to compounds of variable stability, weaker activity, or even the complete loss of antiproliferative effects in vitro. However, one hemisynthetic derivative of narciclasine, compound 7k, demonstrated by both the intravenous and oral routes higher in vivo antitumor activity in human orthotopic glioma models in mice when compared to narciclasine at nontoxic doses. Narciclasine and compound 7k may therefore be of potential use to combat brain tumors.
AuthorsLaurent Ingrassia, Florence Lefranc, Janique Dewelle, Laurent Pottier, Véronique Mathieu, Sabine Spiegl-Kreinecker, Sébastien Sauvage, Mohamed El Yazidi, Mischaël Dehoux, Walter Berger, Eric Van Quaquebeke, Robert Kiss
JournalJournal of medicinal chemistry (J Med Chem) Vol. 52 Issue 4 Pg. 1100-14 (Feb 26 2009) ISSN: 1520-4804 [Electronic] United States
PMID19199649 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amaryllidaceae Alkaloids
  • Antineoplastic Agents
  • Phenanthridines
  • narciclasine
  • Amaryllidaceae Alkaloids (chemistry, pharmacology)
  • Animals
  • Antineoplastic Agents (chemistry, pharmacology)
  • Cell Proliferation
  • Drug Administration Routes
  • Drug Stability
  • Glioma (drug therapy)
  • Humans
  • Mice
  • Phenanthridines (chemistry, pharmacology)
  • Structure-Activity Relationship
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: